Sandoz launches affordable iron sucrose injection for treatment of iron deficiency anemia in patients with chronic kidney disease in USBusiness Wire • 09/24/25
Sandoz launches renewable energy partnership to cover nearly 90% of electricity demand for European operationsGlobeNewsWire • 08/12/25
Sandoz delivers strong H1 2025 results, with accelerated sales growth in the second quarterGlobeNewsWire • 08/07/25
Evotec SE and Sandoz AG Planning Potential Sale of Just - Evotec Biologics Toulouse SiteAccesswire • 07/30/25
Evotec and Sandoz Evolve their Strategic Partnership and Agree on Potential Sale of Just - Evotec Biologics Toulouse SiteAccesswire • 07/30/25
Sandoz signs non-binding term sheet with Evotec SE to acquire its Just-Evotec Biologics in-house development and manufacturing capabilities in Toulouse, FranceGlobeNewsWire • 07/30/25
U.S. and European Union trade deal could cost the pharma industry up to $19 billionFast Company • 07/29/25
EU-US trade deal could add up to $19 billion in pharma industry costs, analysts sayReuters • 07/28/25
3 Generic Drug Stocks to Watch Amid Pricing Pressure & Tariff ThreatsZacks Investment Research • 06/09/25
Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]GlobeNewsWire • 06/02/25
Sandoz launches Pyzchiva® autoinjector, first commercially available in Europe for ustekinumab biosimilarsGlobeNewsWire • 05/21/25
Sandoz reports Q1 2025 net sales in line with company expectations; full-year guidance confirmedGlobeNewsWire • 04/30/25
Sandoz enters global collaboration license agreement with Henlius to commercialize leading oncology therapy, ipilimumab, in multiple indicationsGlobeNewsWire • 04/29/25
Sandoz CEO slams EU-wide drug price proposal, warns US tariffs will hurt patient accessReuters • 04/28/25
Shareholders approve all resolutions proposed by Board of Directors at Annual General Meeting of Sandoz Group AGGlobeNewsWire • 04/15/25
[Corrected] Sandoz files antitrust litigation against Amgen regarding patient access to etanercept biosimilar in the USGlobeNewsWire • 04/14/25
Sandoz files antitrust litigation against Amgen regarding patient access to etanercept biosimilar in the USGlobeNewsWire • 04/14/25